How I Treat Advanced Breast Cancers: A Focus on Targeted Strategies

ACTIVITY OVERVIEW
This Webcast contains video and downloadable slides from the symposium How I Treat Advanced Breast Cancers: A Focus on Targeted Strategies, a prIME Oncology educational activity that was held on 26 September 2011 during the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden.

FACULTY
Chair Nadia Harbeck, MD, PhD University of Cologne Cologne, Germany Faculty Hope Rugo, MD University of California San Francisco San Francisco, California, United States Sunil Verma, MD, MSEd, FRCPC Toronto Sunnybrook Regional Cancer Center Toronto, Ontario, Canada

TARGET AUDIENCE
This educational activity is specifically designed for pan-European medical oncologists, surgical and radiation oncologists, and other healthcare providers interested and/or involved in the treatment of patients with breast cancer.

TOPICS
How I treat ER-positive progressive metastatic breast cancer Hope Rugo, MD How I treat HER2-negative metastatic breast cancer Nadia Harbeck, MD, PhD How I treat HER2-positive metastatic breast cancer Sunil Verma, MD, MSEd, FRCPC

LEARNING OBJECTIVES

After successful completion of this educational activity, participants should be able to:

Describe current standards of care and recent clinical trial data concerning first-line treatment options for patients with HER2-negative metastatic breast cancer, including incorporation of targeted agents when appropriate
Examine the latest treatment approaches for the management of patients with HER2-positive breast cancer, including utilization of novel therapies and combinatorial strategies
Evaluate recent clinical trial data regarding treatment of patients with metastatic endocrine-responsive breast cancer

Organizer
The Webcast is a prIME Oncology activity.

SUPPORT
Support for this activity has been provided by unrestricted educational grants from Novartis Oncology and F. Hoffmann-La Roche Ltd.